Dimensional Fund Advisors LP Mirati Therapeutics, Inc. Transaction History

Dimensional Fund Advisors LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	SELL	$41.99 - $62.38 $9.64 Million - $14.3 Million	-229,663 Reduced 35.24%	422,059 $24.8 Million
Q3 2023 Nov 09, 2023	BUY	$27.8 - $45.35 $4.98 Million - $8.13 Million	179,254 Added 37.94%	651,722 $28.4 Million
Q2 2023 Aug 09, 2023	BUY	$36.13 - $49.49 $6.07 Million - $8.31 Million	167,874 Added 55.11%	472,468 $17.1 Million
Q1 2023 May 12, 2023	BUY	$36.54 - $54.26 $501,876 - $745,261	13,735 Added 4.72%	304,594 $11.3 Million
Q4 2022 Feb 09, 2023	BUY	$41.27 - $98.62 $3.48 Million - $8.32 Million	84,355 Added 40.85%	290,859 $13.2 Million

Q3 2022 Nov 10, 2022	BUY	$59.5 - $86.7 $1.69 Million - $2.46 Million	28,362 Added 15.92%	206,504 $14.4 Million
Q2 2022 Aug 12, 2022	SELL	$39.16 - $88.71 $445,914 - $1.01 Million	-11,387 Reduced 6.01%	178,142 $12 Million
Q1 2022 May 13, 2022	BUY	$75.82 - $150.97 $7.9 Million - $15.7 Million	104,215 Added 122.15%	189,529 $15.6 Million
Q4 2021 Feb 09, 2022	BUY	$132.01 - $190.29 $1.21 Million - $1.74 Million	9,139 Added 12.0%	85,314 $12.5 Million
Q3 2021 Nov 12, 2021	BUY	$132.13 - $177.45 $2.98 Million - $4 Million	22,556 Added 42.07%	76,175 $13.5 Million
Q2 2021 Aug 12, 2021	SELL	$144.0 - $179.73 $207,216 - $258,631	-1,439 Reduced 2.61%	53,619 $8.66 Million
Q1 2021 May 14, 2021	BUY	$158.92 - $221.61 $1.91 Million - $2.66 Million	12,019 Added 27.93%	55,058 $9.43 Million
Q4 2020 Feb 25, 2021	BUY	$162.05 - $240.27 $6.97 Million - $10.3 Million	43,039 New	43,039 $9.45 Million

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.